NCT04140487 2026-04-16Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative NeoplasmM.D. Anderson Cancer CenterPhase 1/2 Recruiting97 enrolled
NCT04771130 2026-04-14A Study of BGB-11417 in Participants With Myeloid MalignanciesBeOne MedicinesPhase 1/2 Recruiting260 enrolled
NCT06661915 2026-04-13A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)National Cancer Institute (NCI)Phase 2 Recruiting62 enrolled